Range
23.36 - 24.69
Vol / Avg.
42.5K/70.9K
Div / Yield
-
52 Wk
15.32 - 63.69
Mkt Cap
486M
Payout Ratio
-
Open
23.5
P/E
-
EPS
-0.56
Shares
20.5M
Outstanding
20.5M
Total Float
8.8M
Benzinga - 2 days ago
Benzinga - Jun 29, 2021, 7:16AM
Benzinga - Jun 21, 2021, 7:33AM
Benzinga - Jun 21, 2021, 6:04AM
Benzinga - Jun 16, 2021, 4:06PM
Benzinga - May 11, 2021, 4:22PM
Benzinga - May 6, 2021, 4:52PM
Benzinga - May 6, 2021, 4:51PM
Benzinga - May 4, 2021, 4:14PM
Benzinga - Mar 31, 2021, 4:19PM
Benzinga - Mar 30, 2021, 7:14AM
Benzinga - Mar 29, 2021, 4:19PM
Benzinga - Mar 29, 2021, 4:07PM
Benzinga - Dec 23, 2020, 7:06AM
Benzinga - Nov 10, 2020, 8:30AM
load more
Sector: Health Care.Industry: Pharmaceuticals
Tarsus Pharmaceuticals Inc is a late clinical-stage biopharmaceutical company. It is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's lead candidate TP-03, is a novel drug that targets the Demodex mite nervous system to kill the mites.

Earnings

see more
Q2 2021Est.ActualSurprise
EPS
(EXPECTED)2021-08-09
REV
Q1 2021Est.ActualSurprise
EPS-0.6400.470 1.1100
REV33.430M33.432M2.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
TARSTarsus Pharmaceuticals0%486M

Tarsus Pharmaceuticals Frequently Asked Questions

Q

How do I buy Tarsus Pharmaceuticals (TARS) stock?

A

You can purchase shares of Tarsus Pharmaceuticals (NASDAQ: TARS) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Tarsus Pharmaceuticals's (TARS) competitors?

A

Other companies in Tarsus Pharmaceuticals’s space includes: Aerie Pharmaceuticals (NASDAQ:AERI), BioDelivery Sciences Intl (NASDAQ:BDSI), ANI Pharmaceuticals (NASDAQ:ANIP), Provention Bio (NASDAQ:PRVB) and Marinus Pharmaceuticals (NASDAQ:MRNS).

Q

What is the target price for Tarsus Pharmaceuticals (TARS) stock?

A

The latest price target for Tarsus Pharmaceuticals (NASDAQ: TARS) was reported by Raymond James on June 29, 2021. The analyst firm set a price target for 50.00 expecting TARS to rise to within 12 months (a possible 111.15% upside). 5 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Tarsus Pharmaceuticals (TARS)?

A

The stock price for Tarsus Pharmaceuticals (NASDAQ: TARS) is $23.68 last updated Today at 8:00:02 PM.

Q

Does Tarsus Pharmaceuticals (TARS) pay a dividend?

A

There are no upcoming dividends for Tarsus Pharmaceuticals.

Q

When is Tarsus Pharmaceuticals (NASDAQ:TARS) reporting earnings?

A
Tarsus Pharmaceuticals’s Q2 earnings are confirmed for after-market on August 9, 2021.
Q

Is Tarsus Pharmaceuticals (TARS) going to split?

A

There is no upcoming split for Tarsus Pharmaceuticals.

Q

What sector and industry does Tarsus Pharmaceuticals (TARS) operate in?

A

Tarsus Pharmaceuticals is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.